The effect of ginger (Zingiber officinale) on glycemic markers in patients with type 2 diabetes

Journal of Complementary and Integrative Medicine

Volumn 12, Issue 2, 2015, Pages 165-170

  Shidfar, Farzad ^a   Rajab, Asadollah ^b   Rahideh, Tayebeh ^a   Khandouzi, Nafiseh ^c   Hosseini, Sharieh ^d   Shidfar, Shahrzad ^e  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Iranian Diabetes Society   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

^e UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

ginger; glycemic markers; paraoxonase; type 2 diabetes

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE 1; C REACTIVE PROTEIN; GINGER EXTRACT; GLUCOSE; HEMOGLOBIN A1C; MALONALDEHYDE; PLACEBO; ANTIDIABETIC AGENT; ARYLDIALKYLPHOSPHATASE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; INSULIN; PLANT EXTRACT; POWDER;

ADULT; AGE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; HUMAN; IRANIAN (CITIZEN); NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TOTAL ANTIOXIDANT CAPACITY; WAIST CIRCUMFERENCE; BLOOD; CHEMISTRY; DIABETES MELLITUS, TYPE 2; DIET SUPPLEMENTATION; FEMALE; GINGER; INSULIN RESISTANCE; IRAN; MALE; METABOLISM; MIDDLE AGED; PHYTOTHERAPY; POWDER; YOUNG ADULT;

ADULT; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; BLOOD GLUCOSE; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GINGER; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; IRAN; MALE; MALONDIALDEHYDE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; POWDERS; YOUNG ADULT;

EID: 84929578706     PISSN: None     EISSN: 15533840     Source Type: Journal    
DOI: 10.1515/jcim-2014-0021     Document Type: Article

References (39)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013;36:S67-74.
2. International Diabetes Federation. IDF guideline for management of post meal glucose in diabetes 2011. Brussels: International Diabetes Federation, 2011.
3. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94:311-21.
4. Webb GP. An overview of dietary supplements and functional food in dietary supplements and functional foods. 1st ed. Blackwell Publishing: Oxford, 2006:1-35.
5. Langner E, Greifenberg S, Gruenwald J. Ginger: history and use. Adv Ther 1998;15:25-44.
6. McKenna DJ, Jones K, Hughes K, Humphrey S. Ginger in botanical medicines, the desk reference for major herbal supplements. 2nd ed. New York, NY: The Haworth Herbal Press, 2002:411-44.
7. Bhattacharjee SK. Zingiber Adams (Boehm) Zingiberaceae. In: Bhattachargee SK, editor. Handbook of aromatic plants. India: Pointer Publisher, 2000:473-4.
8. Ali BH, Blunden G, Tanira MO, Some Phytochemical NA. Pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol 2008;46:409-20.
9. Thomson M, Al-Qattan KK, Al-Sawan SM, Alnaqeeb MA, Khan I, Ali M. The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins Leukot Essent Fatty Acids 2002;67:475-8.
10. Bhandari U, Kanojia R, Pillai KK. Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. J Ethnopharmacol 2005;97:227-30.
11. Bliddal H, Rosetzsky A, Schlichting P, Weidner MS, Andersen LA, Ibfelt HH, et al. A randomized, placebo-controlled, crossover study of ginger extracts and ibuprofen in osteoarthritis. Osteoarthr Cartilage 2000;8:9-12.
12. Jafri SA, Abass S, Qasim M. Hypoglycemic effect of ginger (Zingiber officinale) in alloxan induced diabetic rats (Rattus norvagicus). Pak Vet J 2011;31:160-2.
13. Saraswat M, Suryanarayana P, Paduru Yadagir R, Madhoosudan AP, Nagalla B, Geereddy Bhanuprakash R. Antiglycating potential of Zingiber officinalis and delay of diabetic cataract in rats. Mol Vision 2010;16:1525-37.
14. Priya Rani M, Padmakumari KP, Sankarikutty B, Lijo-Cherian O, Nisha VM, Raghu KG. Inhibitory potential of ginger extracts against enzymes linked to type 2 diabetes, inflammation and induced oxidative stress. Intl J Food Sci Nutr 2011;62:106-10.
15. Li Y, Tran VH, Duke CC, Roufogalis BD. Preventive and protective properties of Zingiber officinale (ginger) in diabetes mellitus, diabetic complications, and associated lipid and other metabolic disorders: a brief review. Evid Based Complement Altern Med 2012, Article ID 516870:10.
16. Ramudu SK, Korivi M, Kesireddy N, Lee LC, Cheng IS, Kuo CH, et al. Nephroprotective effects of a ginger extract on cytosolic and mitochondrial enzymes against streptozotocin (STZ) induced diabetic complications in rats. Chin J Physiol 2011;54:79-86.
17. Rice-Evans C, Miller N. Measurement of the antioxidant status of dietary constituents, low density lipoproteins and plasma. Prostaglandins Leukot Essent Fatty Acids 1997;57:499-505.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-19.
19. Satoh M, Yamasaki Y, Nagake Y, Kasahara J, Hashimoto M, Nakanishi N, et al. Oxidative stress is reduced by the long term use of vitamin E-coated dialysis filters. Kidney Int 1950;2001:1943-50.
20. Gan KN, Smolen A, Eckerson HW, La Du BN. Purification of human serum paraoxonase/arylsterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991;19:100-6.
21. Nammi S, Sreemantula S, Roufogalis BD. Protective effects of ethanolic extract of Zingiber officinale rhizome on the development of metabolic syndrome in high-fat diet-fed rats. Basic Clin Pharmacol Toxicol 2009;104:366-73.
22. Goyal RK, Kadnur SV. Beneficial effects of Zingiber officinale on goldthioglucose induced obesity. Fitoterapia 2006;77: 160-3.
23. Bhandari U, Kanojia R, Pillai KK. Effects of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. J Ethnopharmacol 2005;97:227-30.
24. Shirdel Z, Mirbadalzadeh R, Madani H. Antiglycemic and hypolipidemic effect of ginger in alloxan induced diabetic rats and compare it with the glibenclamide. Iran J Diabetes Lipid Disord 2009;9:7-15. [in Persian].
25. Zhang XF, Tan BK. Effects of an ethanolic extract of Gynura procumbens on serum glucose, cholesterol and triglyceride levels in normal and streptozotocin induced diabetic rats. Singapore Med J 2003;41:1-6.
26. Mozaffari-Khosravi H, Talaei B, Jalai BA, Najarzadeh A, Mozayan MR. The effect of ginger powder supplementation on insulin resistance and glycemic indices in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Complement Ther Med 2014;22:9-16.
27. Arablou T, Aryaeian N, Valizadeh M, Sharifi F, Hosseini A, Djalali M. The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus. Int J Food Sci Nutr 2014;65:515-20.
28. Li Y, Tran VH, Duke CC, Roufogalis BD. Gingerols of Zingiber officinale enhance glucose uptake by increasing cell surface GLUT4 in cultured L6 myotubes. Plant Media 2012;78: 1549-55.
29. Sekiya K, Ohtani A, Kusano S. Enhancement of insulin sensitivity in adipocyte by ginger. Biofactors 2004;22: 153-6.
30. Isa Y, Miyakawa Y, Yanagisawa Mgoto T, Kang MS, Kawada T, et al. 6-Shgoal and 6-gingerol, the pungent of ginger inhibit TNF-? mediated down regulation of adiponectin expression via different mechanism in 3T3-L1 adipocyte. Biochem Biophys Res Commun 2008;373:429-34.
31. Bordia A, Radhika B, Suryakantham V. Effect of aswagandha, ginger and mulberry on hyperglycemia and hyperlipidemia. Plant Foods Human Nutr 2003;58:1-7.
32. Jolad SD, Lantz AM, Guan JC, Chen GI. Fresh organically grown ginger (Zingiber officinale): composition and effects on LPSinduced PGE2 production. Phytochemistry 2004;65:1937-54.
33. Shanmugam KR, Mallikarjuna K, Kesireddy N, Sathyavelu R. Neuroprotective effect of ginger on antioxidant enzymes in streptozotocin induced diabetic rats. Food Chem Toxicol 2011;49:893-7.
34. Mahluji S, Ostadrahimi A, Mobasseri M, Ebrahimzadeh V, Payaboo I. Anti-inflammatory effects of Zingiber officinale in type 2 diabetic patients. Adv Pharmaceut Bull 2013;3: 273-6.
35. Lebda MA, Taha NM, Korshom MA, Mandour A, El-Morshedy AM. Biochemical effect of ginger on some blood and liver parameters in male New Zealand rabiits. Online J Anim Feed Res 2012;2:197-202.
36. Abdul Hanif H, Murad NA, Wan Ngah WZ, Mohd Yusof YA. Effects of Zingiber officinale on superoxide dismutase, glutathione peroxidase, catalase, glutathione and malondialdehyde content in HepG2 cell line. Malays J Biochem Mol Biol 2005;11:36-41.
37. Shidfar F, Heydari I, Hajimiresmaiel SJ, Hosseini S, Shidfar S, Amiri F. The effects of cranberry juice on serum glucose, apoB, apoA-I, Lp(a), and paraoxonase-1 activity in type 2 diabetic male patients. J Res Med Sci 2012;17:355-60.
38. Connelly PW, Zinman B, Maguire GF, Mamakeesick M, Harris SB, Hegele RA, et al. Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes. J Lipid Res 2009;50:1216-22.
39. Shidfar F, Ehramphosh E, Heydari I, Haghighi L, Hosseini SH, Shidfar SH, et al. Effects of soy bean on serum paraoxonase 1 activity and lipoproteins in hyperlipidemic postmenopausal women. Int J Food Sci Nutr 2009;60:195-205.